team_admin

May 4, 2023

Investigating the Assam PCD Pharma Franchise Potential: A Profitable Business Opportunity.

One of the areas with the strongest growth rates worldwide is the pharmaceutical business, and India is no exception. The Indian pharmaceutical market is anticipated to […]
May 2, 2023

US FDA suspends Sun Pharma’s dermatological drug trial.

Deuruxolitinib 12 mg dosage should be stopped by individuals with alopecia areata, an autoimmune disorder that causes patchy hair loss, according to the FDA, according to […]
April 27, 2023

WHO alerted after drug was copied to malign co-chief of India Pharma.

Sudhir Pathak, managing director of QP Pharma Chem Limited, claimed that someone had copied the cough syrup to malign the Indian government after the WHO issued […]
April 21, 2023

Quick-Energy Beverage

The body absorbs vitamin C better when combined with zinc. It offers potent antioxidant defence. aids in preserving regular immune system function both during and after […]
April 14, 2023

Covid & Flu: Increased sales of respiratory and anti-infective medications

Sales of anti-infectives and respiratory medications grew 50% and 49%, respectively, year-over-year despite an increase in Covid-19 and flu cases, according to an IQVIA data. “We […]
April 13, 2023

In the battle over a Parkinson’s medication patent, Teva and Viatris prevailed in the United States.

The Neupro patch patent held by UCB was found to be invalid by the United States Court of Appeals for the Federal Circuit. The U.S. Food […]
April 1, 2023

Lupin receives USFDA approval for a generic antiviral drug

It was added that the company’s product is a generic version of the 25 mg Vemlidy pills produced by Gilead Sciences Inc. According to Lupin, the […]
March 30, 2023

Indian pharmaceutical company Granules develops a packaging facility in Virginia, USA.

According to Dr. Krishna Prasad Chigurupati, the company’s founder, chairman, and managing director, Granules has invested more than USD 100 million in the nation. Granules was […]
March 25, 2023

According to Bayer, women’s health is no longer a priority in medication research.

Bayer, the maker of the Yasmin brand of birth-control pills and the Mirena intrauterine device, added it would nevertheless continue to pursue the development of non-hormonal […]